Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers
byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainTG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease rela
Updated on: April 28,2024
0

Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers
byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainTG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease rela
Updated on:April 28,2024
0
